Drug Shortage Report for ACT CIPROFLOXACIN
| Report ID | 133460 |
| Drug Identification Number | 02247340 |
| Brand name | ACT CIPROFLOXACIN |
| Common or Proper name | CIPROFLOXACIN 500MG FC TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-02-03 |
| Estimated end date | Unknown |
| Actual end date | 2023-06-08 |
| Shortage status | Resolved |
| Updated date | 2023-06-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2023-06-09 | English | Compare |
| v16 | 2023-06-08 | French | Compare |
| v15 | 2023-06-08 | English | Compare |
| v14 | 2022-08-18 | French | Compare |
| v13 | 2022-08-18 | English | Compare |
| v12 | 2022-06-30 | French | Compare |
| v11 | 2022-06-30 | English | Compare |
| v10 | 2022-04-01 | French | Compare |
| v9 | 2022-04-01 | English | Compare |
| v8 | 2021-07-22 | French | Compare |
| v7 | 2021-07-22 | English | Compare |
| v6 | 2021-05-13 | French | Compare |
| v5 | 2021-05-13 | English | Compare |
| v4 | 2021-05-13 | English | Compare |
| v3 | 2021-05-13 | English | Compare |
| v2 | 2021-02-05 | French | Compare |
| v1 | 2021-02-05 | English | Compare |
Showing 1 to 17 of 17